Literature DB >> 21681364

Pre-treatment evaluation of basal cell carcinoma for photodynamic therapy: comparative measurement of tumour thickness in punch biopsy and excision specimens.

Eidi Christensen1, Patricia Mjønes, Olav Andreas Foss, Ole Martin Rørdam, Eirik Skogvoll.   

Abstract

Tumour thickness affects the outcome of photodynamic therapy in basal cell carcinoma (BCC). The aim of this study was to evaluate whether punch biopsy provides reliable information on BCC tumour thickness, by comparing corresponding measurements in biopsy and excision specimens for 48 lesions in 43 patients. BCC tumours were between 0.2 and 6.1 mm thick. The mean depth of the excisions were 0.14 mm greater than that of the biopsies. Bland-Altman 95% limits of agreement were (-1.3, 1.6) mm, but the difference between measurements increased with tumour thickness. A punch biopsy tumour thickness of 1.0 mm yielded an upper 95% predicted limit for excision depth within 2.0 mm. In conclusion, there was reasonable overall agreement between corresponding measurements. A biopsy thickness of 1.0 mm suggests that the tumour will most likely be within the current accepted limits for photodynamic therapy. With increasing tumour thickness, however, individual tumour measurements may differ considerably.

Entities:  

Mesh:

Year:  2011        PMID: 21681364     DOI: 10.2340/00015555-1127

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  2 in total

1.  Pre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy.

Authors:  Eidi Christensen; Cato Mørk; Olav Andreas Foss
Journal:  J Skin Cancer       Date:  2011-11-15

2.  Is There a Relationship between the Stratum Corneum Thickness and That of the Viable Parts of Tumour Cells in Basal Cell Carcinoma?

Authors:  Olav A Foss; Patricia Mjønes; Silje Fismen; Eidi Christensen
Journal:  J Skin Cancer       Date:  2016-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.